Logo image
Se connecter
Impact of Nirsevimab on Respiratory Syncytial Virus Bronchiolitis in Hospitalized Infants: A Real-World Study
Article de revue   Avec comité de lecture

Impact of Nirsevimab on Respiratory Syncytial Virus Bronchiolitis in Hospitalized Infants: A Real-World Study

Eric Jeziorski, Antoine Ouziel, Marie Cotillon, Constance Bridonneau, Etienne Bizot, Clément Basse, Aurélie Portefaix, François Dubos, Stéphane Béchet, Lea Domitien, …
The Pediatric infectious disease journal, Vol.44(4), pp.e124-e126
04/2025
PMID: 39589139

Résumé

Brief Reports
Regarding nirsevimab immunization status, among 1085 infants hospitalized for bronchiolitis, the odds of hospitalization for respiratory syncytial virus bronchiolitis were 4.7 times higher for nonimmunized children. Immunized infants were less likely to require oxygen supplementation (20.2% vs. 30.6%, P = 0.02) and had a 1-day shorter hospital stay. Respiratory syncytial virus bronchiolitis was less frequent and less severe in infants immunized with nirsevimab.

Indicateurs

1 Consultations de la notice

Détails

Logo image